IVF Product Market, Global Scenario, Market Size, Outlook, Trend and Forecast 2018-2026
The global in-vitro fertilization (IVF) product market is expected to reach $ 7,732 Million by 2026; with a CAGR of 16.6% from 2019 to 2026.The exponential rise in the IVF services market & the use of associated IVF Product invariably boost the global market. Due to technological innovation in the reproductive technologies & related equipment market is estimated to propel the growth.
The key market drivers of the global IVF product market are the increased rate of success in the IVF technology along with the higher spending on the healthcare budget, changing overall socio-economic dynamics related to having the child also boost the market in various ways. However, the high initial set up cost of the IVF product market & lack of awareness may hamper the market. On the contrary, increasing the investment in the research & development related to the IVF product further augment the global market.
The global IVF product market is segmented into product, end-use, technology & geography. By product, the market is divided into accessory and disposable, instrument, reagent & media. By end-use the market divided into hospitals, fertility clinics, surgical centers and clinical research institutes. By technology, the market is divided into fresh embryo egg, frozen embryo egg and donor embryo. The global IVF product market is divided under various geographical regions such as North America, Asia-Pacific, Europe, and Rest of the World (RoW).
The country-wise analysis has been also covered under the scope of the report. North America covers the U.S., Canada, and Mexico while Europe covers Germany, France, Italy, and UK & Rest of Europe. Japan, China, Russia, India, South Korea, Australia, and Rest of Asia-Pacific have been analyzed under the Asia-Pacific market. Rest of the world (RoW) includes Central & South America, the Middle East, and Africa.
The scope of the report covers in-depth analysis of the market in terms of both qualitative and quantitative analysis across the segments as well as cross-sectional analysis of the segments including the geographies and its countries. The market has been analyzed both from demand as well as supply side to come to an accurate scenario. Products across application and application across geographies have been mapped to provide you a precise competitive scenario to have a leading edge in the market.
Key companies operating in this market and their company profile along with the market share analysis and competitive scenario is also part of the report. Top players are Genea Biomedx, Vitrolife AB, Millendo Therapeutics Inc, Ovascience Inc. Oxford Gene Technology, Thermo Fisher Scientific, Inc., Millendo Therapeutics, Inc, Fujifilm Holdings Corporation (Irvine Scientific Sales Company), Cook Medical Inc., Southend Fertility and IVF Centre, and others.
The Highlights of the Report
Scope of the Global IVF product Market
By End Use